ASSET | DATE | % RETURN |
---|---|---|
Bright Minds Biosciences (DRUG) | 8/1/2022 - 8/30/2022 | 134.02% |
Astria Therapeutics (ATXS) | 8/1/2022 - 8/30/2022 | 102.21% |
Cooper Stnd (CPS) | 8/1/2022 - 8/30/2022 | 85.29% |
Aquestive Therapeutics (AQST) | 8/1/2022 - 8/30/2022 | 80.95% |
Terns Pharmaceuticals (TERN) | 8/1/2022 - 8/30/2022 | 79.91% |
Viridian Therapeutics (VRDN) | 8/1/2022 - 8/30/2022 | 66.16% |
Arhaus (ARHS) | 8/1/2022 - 8/30/2022 | 60.29% |
Verve Therapeutics (VERV) | 8/1/2022 - 8/30/2022 | 55.12% |
Pharming Group N.V. (PHAR) | 8/1/2022 - 8/30/2022 | 50.59% |
Immunome (IMNM) | 8/1/2022 - 8/30/2022 | 50.13% |
EVI Industries (EVI) | 8/1/2022 - 8/30/2022 | 48.61% |
Larimar Therapeutics (LRMR) | 8/1/2022 - 8/30/2022 | 48.13% |
Precigen (PGEN) | 8/1/2022 - 8/30/2022 | 47.37% |
Limbach (LMB) | 8/1/2022 - 8/30/2022 | 46.17% |
Cogent Biosciences (COGT) | 8/1/2022 - 8/30/2022 | 43.42% |
Semler Scientific (SMLR) | 8/1/2022 - 8/30/2022 | 43.03% |
Fubotv (FUBO) | 8/1/2022 - 8/30/2022 | 42.17% |
Aldeyra (ALDX) | 8/1/2022 - 8/30/2022 | 41.97% |
SS Innovations International Inc Common Stock (SSII) | 8/1/2022 - 8/30/2022 | 41.94% |
Avadel Pharmaceuticals (AVDL) | 8/1/2022 - 8/30/2022 | 41.72% |
Applied Opt (AAOI) | 8/1/2022 - 8/30/2022 | 41.18% |
Canopy Growth (CGC) | 8/1/2022 - 8/30/2022 | 39.92% |
Fluence Energy (FLNC) | 8/1/2022 - 8/30/2022 | 39.33% |
Calumet Specialty Products Partners (CLMT) | 8/1/2022 - 8/30/2022 | 37.29% |
Jumia Technologies (JMIA) | 8/1/2022 - 8/30/2022 | 36.65% |